Research has shown that targeting the JAK-STAT signaling pathway can control cytokine release in patients with COVID-19 32, and targeting the PI3K/Akt/mTOR pathway is a potential strategy for treating COVID-19 33. The gene discussed is AKT1; the disease is COVID-19.